Romy N Bouwmeester Mendy Ter Avest Kioa L Wijnsma Caroline Duineveld Rob Ter Heine Elena B Volokhina Lambertus P W J Van Den Heuvel Jack F M Wetzels Nicole C A J van de Kar
10.3389/fimmu.2020.612706
Front Immunol
2021 Jan 15;11:612706.
ahus atypical hemolytic uremic syndrome eculizumab pharmacokinetic proteinuria therapeutic drug monitoring
CC BY
https://pubmed.ncbi.nlm.nih.gov/33519821/
Antibodies, Monoclonal, Humanized / pharmacokinetics Antibodies, Monoclonal, Humanized / therapeutic use Atypical Hemolytic Uremic Syndrome / drug therapy
Antibodies, Monoclonal, Humanized / pharmacokinetics Antibodies, Monoclonal, Humanized / therapeutic use Atypical Hemolytic Uremic Syndrome / drug therapy Case Reports Adolescent Atypical Hemolytic Uremic Syndrome / metabolism Complement Factor H / metabolism Humans Male Retrospective Studies Antibodies, Monoclonal, Humanized Complement Factor H eculizumab
PMC7843372
33519821
Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
2021